OpenURL Connection Search

Select item for more details and to access through your institution.

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.
Published in:
Case Reports in Oncological Medicine, 2022, p. 1, doi. 10.1155/2022/2658136
By:
- Kissoonsingh, P.;
- Sutton, B.;
- Iqbal, Syed U.;
- Pallan, Lalit;
- Steven, Neil;
- Khoja, L.
Publication type:
Article
Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts.
Published in:
European Journal of Immunology, 2011, v. 41, n. 12, p. 3506, doi. 10.1002/eji.201141762
By:
- Marshall, Jennifer L.;
- Zhang, Yang;
- Pallan, Lalit;
- Hsu, Mei-Chi;
- Khan, Mahmood;
- Cunningham, Adam F.;
- MacLennan, Ian C. M.;
- Toellner, Kai-Michael
Publication type:
Article
Cover Picture: Eur. J. Immunol. 12/11.
Published in:
European Journal of Immunology, 2011, v. 41, n. 12, p. n/a, doi. 10.1002/eji.201190077
By:
- Marshall, Jennifer L.;
- Zhang, Yang;
- Pallan, Lalit;
- Hsu, Mei-Chi;
- Khan, Mahmood;
- Cunningham, Adam F.;
- MacLennan, Ian C. M.;
- Toellner, Kai-Michael
Publication type:
Article
CDK4/6 inhibitors in metastatic breast cancer, a comparison of toxicity and efficacy across agents in a real-world dataset.
Published in:
Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1825, doi. 10.1177/10781552231163121
By:
- Buller, William;
- Pallan, Lalit;
- Chu, Teresa;
- Khoja, Leila
Publication type:
Article
Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Published in:
Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1163, doi. 10.1177/10781552221103548
By:
- Tew, Alice;
- Khoja, Leila;
- Pallan, Lalit;
- Steven, Neil
Publication type:
Article
Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study*.
Published in:
British Journal of Dermatology, 2022, v. 187, n. 3, p. 401, doi. 10.1111/bjd.21241
By:
- Bai, Xue;
- Shoushtari, Alexander N.;
- Betof Warner, Allison;
- Si, Lu;
- Tang, Bixia;
- Cui, Chuanliang;
- Yang, Xiaoling;
- Wei, Xiaoting;
- Quach, Henry T.;
- Cann, Christopher G.;
- Zhang, Michael Z.;
- Pallan, Lalit;
- Harvey, Catriona;
- Kim, Michelle S.;
- Kasumova, Gyulnara;
- Sharova, Tatyana;
- Cohen, Justine V.;
- Lawrence, Donald P.;
- Freedman, Christine;
- Fadden, Riley M.
Publication type:
Article
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Published in:
2021
By:
- Bhave, Prachi;
- Pallan, Lalit;
- Long, Georgina V.;
- Menzies, Alexander M.;
- Atkinson, Victoria;
- Cohen, Justine V.;
- Sullivan, Ryan J.;
- Chiarion-Sileni, Vanna;
- Nyakas, Marta;
- Kahler, Katharina;
- Hauschild, Axel;
- Plummer, Ruth;
- Trojaniello, Claudia;
- Ascierto, Paolo A.;
- Zimmer, Lisa;
- Schadendorf, Dirk;
- Allayous, Clara;
- Lebbe, Celeste;
- Maurichi, Andrea;
- Santinami, Mario
Publication type:
journal article

Found: 7

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.

Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts.

Cover Picture: Eur. J. Immunol. 12/11.

CDK4/6 inhibitors in metastatic breast cancer, a comparison of toxicity and efficacy across agents in a real-world dataset.

Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.

Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study*.

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.